Respreeza - supply shortage
Resolved
alpha1-proteinase inhibitor (human)
ShortageHuman
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
Shortage information
The shortage affecting Respreeza has been resolved and the information and recommendations which were issued during the shortage no longer apply.
Key facts
- Medicines affected
- Respreeza
- Supply shortage status
- Resolved
- International non-proprietary name (INN) or common name
- alpha1-proteinase inhibitor (human)
- Therapeutic area (MESH)
- Genetic Diseases, Inborn
- Lung Diseases
- Pharmaceutical forms affected
- Powder and solvent for solution for infusion
- Strengths affected
- 1,000 mg
- 4,000 mg
- 5,000 mg
- Availability of alternatives
- Yes
Key dates
- First published
- Last updated